1. Home
  2. LUNG vs FLYX Comparison

LUNG vs FLYX Comparison

Compare LUNG & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • FLYX
  • Stock Information
  • Founded
  • LUNG 1995
  • FLYX 2015
  • Country
  • LUNG United States
  • FLYX United States
  • Employees
  • LUNG 291
  • FLYX N/A
  • Industry
  • LUNG Industrial Specialties
  • FLYX Blank Checks
  • Sector
  • LUNG Health Care
  • FLYX Finance
  • Exchange
  • LUNG Nasdaq
  • FLYX Nasdaq
  • Market Cap
  • LUNG 299.3M
  • FLYX 264.1M
  • IPO Year
  • LUNG 2020
  • FLYX N/A
  • Fundamental
  • Price
  • LUNG $7.52
  • FLYX $3.05
  • Analyst Decision
  • LUNG Strong Buy
  • FLYX
  • Analyst Count
  • LUNG 7
  • FLYX 0
  • Target Price
  • LUNG $12.64
  • FLYX N/A
  • AVG Volume (30 Days)
  • LUNG 493.3K
  • FLYX 35.5K
  • Earning Date
  • LUNG 04-30-2025
  • FLYX 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • FLYX N/A
  • EPS Growth
  • LUNG N/A
  • FLYX N/A
  • EPS
  • LUNG N/A
  • FLYX N/A
  • Revenue
  • LUNG $83,789,000.00
  • FLYX $311,873,000.00
  • Revenue This Year
  • LUNG $17.96
  • FLYX $4.63
  • Revenue Next Year
  • LUNG $18.35
  • FLYX $33.97
  • P/E Ratio
  • LUNG N/A
  • FLYX N/A
  • Revenue Growth
  • LUNG 22.01
  • FLYX N/A
  • 52 Week Low
  • LUNG $5.46
  • FLYX $1.79
  • 52 Week High
  • LUNG $10.01
  • FLYX $18.99
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 50.11
  • FLYX 44.17
  • Support Level
  • LUNG $6.97
  • FLYX $3.00
  • Resistance Level
  • LUNG $7.65
  • FLYX $3.35
  • Average True Range (ATR)
  • LUNG 0.67
  • FLYX 0.35
  • MACD
  • LUNG -0.18
  • FLYX -0.04
  • Stochastic Oscillator
  • LUNG 23.40
  • FLYX 18.99

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

Share on Social Networks: